EBITDA Summary of Abnova (Taiwan) Corporation

Abnova (Taiwan) Corporation's latest annual EBITDA in 2023 was 81.2 Million TWD , down -40.2% from previous year.
Abnova (Taiwan) Corporation's latest quarterly EBITDA in 2024 Q1 was 35.54 Million TWD , up 307.34% from previous quarter.
Abnova (Taiwan) Corporation reported an annual EBITDA of 130.29 Million TWD in 2022, up 63.3% from previous year.
Abnova (Taiwan) Corporation reported an annual EBITDA of 79.79 Million TWD in 2021, down -17.96% from previous year.
Abnova (Taiwan) Corporation reported a quarterly EBITDA of 35.54 Million TWD for 2024 Q1, up 307.34% from previous quarter.
Abnova (Taiwan) Corporation reported a quarterly EBITDA of 23.65 Million TWD for 2023 Q3, down -8.23% from previous quarter.

Annual EBITDA Chart of Abnova (Taiwan) Corporation (2023 - 2009)

Historical Annual EBITDA of Abnova (Taiwan) Corporation (2023 - 2009)

Year	EBITDA	EBITDA Growth
2023	81.2 Million TWD	-40.2%
2022	130.29 Million TWD	63.3%
2021	79.79 Million TWD	-17.96%
2020	97.25 Million TWD	28.98%
2019	75.4 Million TWD	-5.15%
2018	78.52 Million TWD	-27.32%
2017	108.26 Million TWD	29.75%
2016	84.31 Million TWD	-3.38%
2015	87.26 Million TWD	-13.77%
2014	81.35 Million TWD	-14.67%
2013	118.59 Million TWD	-12.02%
2012	134.49 Million TWD	-22.91%
2011	175.63 Million TWD	-6.95%
2010	188.38 Million TWD	15.37%
2009	162.48 Million TWD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	18.27 Million TWD	-48.57%
2024 Q1	35.54 Million TWD	307.34%
2023 Q3	23.65 Million TWD	-8.23%
2023 Q1	20.06 Million TWD	-6.61%
2023 FY	- TWD	-40.2%
2023 Q2	25.77 Million TWD	28.49%
2023 Q4	8.42 Million TWD	-64.4%
2022 FY	- TWD	63.3%
2022 Q2	33.99 Million TWD	9.55%
2022 Q3	43.78 Million TWD	28.8%
2022 Q4	21.48 Million TWD	-50.94%
2022 Q1	31.03 Million TWD	256.4%
2021 Q2	20.79 Million TWD	-12.92%
2021 Q1	23.87 Million TWD	-2.41%
2021 Q4	8.7 Million TWD	-67.04%
2021 FY	- TWD	-17.96%
2021 Q3	26.41 Million TWD	27.08%
2020 Q3	32.58 Million TWD	85.79%
2020 FY	- TWD	28.98%
2020 Q1	22.66 Million TWD	10.32%
2020 Q2	17.54 Million TWD	-22.62%
2020 Q4	24.46 Million TWD	-24.93%
2019 Q3	21.84 Million TWD	10.1%
2019 FY	- TWD	-5.15%
2019 Q1	13.18 Million TWD	-25.29%
2019 Q4	20.54 Million TWD	-5.92%
2019 Q2	19.83 Million TWD	50.47%
2018 Q3	19.78 Million TWD	18.9%
2018 Q2	16.64 Million TWD	-11.76%
2018 FY	- TWD	-27.32%
2018 Q4	17.64 Million TWD	-10.83%
2018 Q1	18.85 Million TWD	-35.86%
2017 Q2	21.54 Million TWD	-6.37%
2017 Q4	29.4 Million TWD	7.52%
2017 Q1	23 Million TWD	2.76%
2017 FY	- TWD	29.75%
2017 Q3	27.34 Million TWD	26.94%
2016 Q2	17.81 Million TWD	-33.6%
2016 FY	- TWD	-3.38%
2016 Q4	22.39 Million TWD	29.59%
2016 Q3	17.27 Million TWD	-3.02%
2016 Q1	26.83 Million TWD	28.71%
2015 FY	- TWD	-13.77%
2015 Q4	20.84 Million TWD	81.93%
2015 Q2	40.86 Million TWD	189.99%
2015 Q3	11.45 Million TWD	-71.96%
2015 Q1	14.09 Million TWD	-49.48%
2014 Q3	25.42 Million TWD	1.72%
2014 FY	- TWD	-14.67%
2014 Q4	27.89 Million TWD	9.73%
2014 Q2	24.99 Million TWD	9.2%
2014 Q1	22.88 Million TWD	-5.56%
2013 Q3	26.88 Million TWD	-11.7%
2013 Q4	24.23 Million TWD	-9.87%
2013 FY	- TWD	-12.02%
2013 Q1	37.02 Million TWD	17.52%
2013 Q2	30.45 Million TWD	-17.75%
2012 Q3	31.5 Million TWD	5.58%
2012 FY	- TWD	-22.91%
2012 Q4	31.5 Million TWD	-0.02%
2012 Q2	29.84 Million TWD	-28.47%
2012 Q1	41.71 Million TWD	-3.69%
2011 Q3	44.18 Million TWD	9.53%
2011 Q4	43.31 Million TWD	-1.96%
2011 FY	- TWD	-6.95%
2011 Q1	47.02 Million TWD	25.58%
2011 Q2	40.33 Million TWD	-14.22%
2010 Q1	46.03 Million TWD	0.0%
2010 FY	- TWD	15.37%
2010 Q3	53.88 Million TWD	6.59%
2010 Q4	37.44 Million TWD	-30.51%
2010 Q2	50.55 Million TWD	9.82%
2009 FY	- TWD	0.0%

Peer EBITDA Comparison of Abnova (Taiwan) Corporation

Name	EBITDA	EBITDA Difference
Apex Biotechnology Corp.	221.06 Million TWD	63.264%
Sinphar Pharmaceutical Co.,Ltd.	582.94 Million TWD	86.069%
Panion & Bf Biotech Inc.	327.21 Million TWD	75.182%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	473.81 Million TWD	82.861%
GenMont Biotech Incorporation	71.76 Million TWD	-13.155%
Adimmune Corporation	-512.42 Million TWD	115.848%
Tanvex BioPharma, Inc.	-1.75 Billion TWD	104.629%
Polaris Group	-1.38 Billion TWD	105.844%
Energenesis Biomedical CO.,LTD.	-244.57 Million TWD	133.204%
UnicoCell Biomed Co., Ltd.	-56.27 Million TWD	244.305%
PELL Bio-Med Technology Co. Ltd.	-353.17 Million TWD	122.994%

Global Stocks Search

Abnova (Taiwan) Corporation (4133.TW)

EBITDA Summary of Abnova (Taiwan) Corporation

Annual EBITDA Chart of Abnova (Taiwan) Corporation (2023 - 2009)

Historical Annual EBITDA of Abnova (Taiwan) Corporation (2023 - 2009)

Peer EBITDA Comparison of Abnova (Taiwan) Corporation